LPL Financial LLC Buys 2,426 Shares of Humana Inc. (NYSE:HUM)

Key Points

• LPL Financial LLC increased its holdings in Humana Inc. by 7.4%, acquiring an additional 2,426 shares for a total of 35,005 shares valued at approximately $9.26 million.
• Several institutional investors, including Riverview Trust Co. and Whipplewood Advisors LLC, also modified their stakes in Humana, contributing to 92.38% of the company's stock being owned by institutional investors.
• Analysts have adjusted their price targets for Humana, with consensus now at $281.62, indicating a mixed outlook with seventeen "hold" ratings and seven "buy" ratings among analysts.

LPL Financial LLC increased its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 7.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 35,005 shares of the insurance provider's stock after acquiring an additional 2,426 shares during the period. LPL Financial LLC's holdings in Humana were worth $9,262,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Texas Yale Capital Corp. purchased a new position in Humana in the 1st quarter worth about $357,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Humana by 1.4% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 54,488 shares of the insurance provider's stock worth $14,418,000 after buying an additional 750 shares during the period. Empirical Finance LLC boosted its holdings in shares of Humana by 2.5% in the first quarter. Empirical Finance LLC now owns 4,383 shares of the insurance provider's stock worth $1,160,000 after buying an additional 107 shares during the period. HB Wealth Management LLC increased its holdings in shares of Humana by 12.0% in the 1st quarter. HB Wealth Management LLC now owns 3,776 shares of the insurance provider's stock valued at $999,000 after purchasing an additional 406 shares during the period. Finally, Applied Finance Capital Management LLC increased its holdings in shares of Humana by 1.7% in the 1st quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider's stock valued at $779,000 after purchasing an additional 48 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of research reports. Bank of America dropped their target price on Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a report on Tuesday, June 17th. Barclays set a $275.00 price target on Humana and gave the company an "equal weight" rating in a research note on Thursday, July 31st. Robert W. Baird lowered their price target on Humana from $300.00 to $297.00 and set a "neutral" rating for the company in a research note on Friday, July 25th. Morgan Stanley lowered their price target on Humana from $290.00 to $277.00 and set an "equal weight" rating for the company in a research note on Thursday, July 31st. Finally, Wells Fargo & Company set a $348.00 price target on Humana in a research note on Friday, July 18th. Seventeen research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $281.62.

Humana Stock Performance

Shares of HUM stock traded up $8.50 during trading hours on Tuesday, reaching $275.17. 1,547,126 shares of the company's stock were exchanged, compared to its average volume of 2,055,104. The business has a fifty day moving average price of $238.61 and a 200-day moving average price of $253.70. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $33.09 billion, a P/E ratio of 21.12, a P/E/G ratio of 1.57 and a beta of 0.44. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $382.72.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The firm had revenue of $32.39 billion during the quarter, compared to analyst estimates of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The business's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.96 earnings per share. Analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.